Article

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine

2021-09-01

Abstract excerpt

The BNT162b2 vaccine showed high real-life effectiveness both at preventing disease and in reducing viral loads of breakthrough infections, but coincidental with the rise of the Delta-variant SARS-CoV2, these protective effects have been decreasing, prompting a third, booster, vaccine inoculation. Here, analyzing viral loads of over 11,000 infections during the current wave in Israel, we find that even though this...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0cf48afb-641f-53be-8d14-e291361396d6
DOI: 10.1101/2021.08.29.21262798

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccineDOI 10.1101/2021.08.29.21262798Read

Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responsesSemantic proximity Read

Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary StudySemantic proximity Read

SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccinationSemantic proximity Read

Age Dependent Reduction of Neutralization Capacities Against Delta Variant Five Months Post-Vaccination (BNT162b2)Semantic proximity Read

Investigation of Vaccine Breakthrough Infections by Vaccine strategy during the Delta Variant Wave in FranceSemantic proximity Read

Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpointSemantic proximity Read

Active immunization by COVID-19 mRNA vaccine results in rapid antibody response and virus reduction in breakthrough infection by Delta (B.1.617.2)Semantic proximity Read

The Effectiveness of the First Dose of BNT162b2 Vaccine in Reducing SARS-CoV-2 Infection: Real-World EvidenceSemantic proximity Read

Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in QatarSemantic proximity Read

Third dose vaccine With BNT162b2 and its response on Long COVID after Breakthrough infectionsSemantic proximity Read

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infectionsSemantic proximity Read

Duration of viral shedding and culture positivity with post-vaccination breakthrough delta variant infectionsSemantic proximity Read